ENZ (Enzo Biochem, Inc.) Earnings per share growth rate in current year

ENZ (Enzo Biochem) - company brandmark

Enzo Biochem, Inc. (ENZ) efficiency is based on the automation of test production, which reduces costs despite high R&D expenditures. The GURU.Markets interface displays the relative annual earnings per share growth rate, where the value remains at 0.00. The company's revenues rely on the sale of oncology diagnostic reagents, while the current strategy focuses on implementing innovative products in clinics.

ENZ - Enzo Biochem Net earnings per share growth this year over the range 07/04/2022 - 04/26/2025

Comprehensive metric breakdowns and analytics for enzo.com (ENZ)

- current quotes and average value forecast:
Market Chart Enzo Biochem|ENZ - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Enzo Biochem, Inc.|ENZ - Total Company Value
- balance sheet equity data:
Equity per Share Enzo Biochem|ENZ - Company Net Assets|Market Capitalization to Net Assets enzo.com|ENZ - Aggregate Company Assets
- debt and liquidity details:
Debt to Capital Enzo Biochem, Inc.|ENZ - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Enzo Biochem|ENZ - Company Aggregate Debts|Debt to Book Capitalization Ratio Enzo Biochem, Inc.|ENZ - Company Long-Term Debts|Short-Term Debt Volume Enzo Biochem|Immediate Liquidity enzo.com
- earnings and market ratios statistics:
ENZ - Net Profit|Future Profit Enzo Biochem, Inc.|ENZ - P/E Multiple|Future Price to Earnings Multiple Enzo Biochem|ENZ - PEG Multiple|Company Value to EBITDA Enzo Biochem, Inc.|ENZ - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Enzo Biochem|ENZ - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months enzo.com|ENZ - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Enzo Biochem, Inc.
Fundamental valuation:Enzo, ENZ
Signature product of Enzo Biochem Inc.

Enzo Biochem, Inc. (ENZ) is monetizing a vast patent portfolio for DNA labeling amidst fierce competition in the molecular diagnostics market. This metric captures the percentage deviation of current earnings per share from the same period last year, measuring the dynamics of business efficiency. Analyzing the annual EPS growth rate on the GURU.Markets platform allows investors to assess the stability of the issuer's fundamental position and promptly identify a shift in the profitability trend.

Direct competitors

A - Expected net earnings per share growth this year|DGX (Quest) - Earnings growth in current year|Earnings per share growth rate in current year Illumina Platform ILMN|Earnings per share growth in current year Exact Sciences (EXAS)|revvity.com - Earnings per share growth this year|Bio-Rad - Net earnings per share growth this year|NNNN (Anbio Biotechnology Ltd) - Earnings per share trend in current year|SHC - Earnings per share growth in current year|Earnings per share growth rate in current year QuidelOrtho Inc.|OPK (OPKO Health, Inc.) - Net earnings per share growth this year|CareDx - Earnings per share increase in current year|MRVI (Maravai LifeSciences Holdings, Inc.) - Earnings growth in current year|Earnings per share growth in current year FLGT|Earnings growth in current year LAB|Expected net earnings per share growth this year Cytek Corp|Earnings per share growth in current year OraSure Technologies OSUR|Exagen Inc (XGN) - Earnings per share growth rate in current year|MDxHealth - Earnings growth in current year|Lucid Diagnostics, Inc. (LUCD) - Net earnings per share growth this year|PRE: Earnings growth in current year|Insight Molecular Diagnostics Inc - Earnings per share increase in current year|TRIB (Trinity Biotech PLC) - Earnings growth in current year|Earnings per share growth rate in current year prophaselabs.com PRPH|Earnings per share growth in current year Ainos (AIMD)|Net earnings per share growth this year Co-Diagnostics Inc CODX|Heart Test Laboratories Inc. - Net earnings per share growth this year|Earnings per share increase in current year BMRA|Cardio Diagnostics Holdings, Inc. - Earnings growth in current year|Expected net earnings per share growth this year onconetix.gcs-web.com ONCO|Virax Biolabs (VRAX) - Earnings per share growth in current year|Earnings per share growth this year BJDX|AWH (Vermillion) - Earnings growth in current year|Net earnings per share growth this year Accelerate Diagnostics Inc (AXDX)|Net earnings per share growth this year CNTG (Centogene NV)|Expected net earnings per share growth this year fresh2.co|Earnings growth in current year GENE (Genetic Technologies Limited)|23andMe Holding Co (ME) - Earnings per share growth rate in current year|PMD - Earnings per share growth in current year